Desmopressin (DDAVP): what it is and what the evidence says
A synthetic vasopressin analogue that acts selectively on the renal V2 receptor, concentrating the urine.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Hormones work in axes: a signal from the brain tells a gland to release another hormone, and so on down the chain, with brakes that shut the process off. Intervening at one point has consequences both upstream and downstream. That is why this is the group where professional assessment stops being a recommendation and becomes essential.
What it is studied for
Central diabetes insipidus, enuresis, nocturia, some bleeding disorders.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
A synthetic vasopressin analogue with decades of clinical use and solid evidence: multiple randomised double-blind trials, including phase 3 studies in nocturia, on top of its established role in central diabetes insipidus, nocturnal enuresis and certain bleeding disorders.
The limitation that matters most
Its main risk is dilutional hyponatraemia, which can be severe and cause seizures, particularly in people over 65 and when fluid intake is not restricted. It requires sodium monitoring before and during treatment. This is not an 'optimisation' peptide: it is a drug with specific indications and mandatory medical supervision.
Regulatory status
Approved by the FDA and the EMA for central diabetes insipidus, nocturnal enuresis, nocturia and selected bleeding disorders.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Prescription medicine. Risk of severe hyponatraemia if fluid intake is not controlled.
Management always belongs to a physician, and headache, nausea, confusion or swelling calls for immediate consultation because sodium may be falling.
What this page cannot give you
A reference page can take you this far. You know what Desmopressin (DDAVP) is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
Some title in this list contains a figure, because that is how the study was published and we reproduce titles verbatim: trimming them would make the citation impossible to verify. A title is not a protocol. What amount suits a particular person is decided by a professional who knows their case, never by the headline of a trial.
- New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance)review J Neuroendocrinol · 2023 · PMID 36683321 →
- Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group studyhuman J Urol · 2013 · PMID 23454404 →
- Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Studyhuman J Urol · 2017 · PMID 27622611 →
- Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development programhuman Low Urin Tract Symptoms · 2020 · PMID 31397969 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Desmopressin (DDAVP) or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Desmopressin (DDAVP)?
A synthetic vasopressin analogue that acts selectively on the renal V2 receptor, concentrating the urine. It is studied within the area of hormonal/sexual.
Is there human evidence for Desmopressin (DDAVP)?
A synthetic vasopressin analogue with decades of clinical use and solid evidence: multiple randomised double-blind trials, including phase 3 studies in nocturia, on top of its established role in central diabetes insipidus, nocturnal enuresis and certain bleeding disorders.
Is it approved by any health agency?
Approved by the FDA and the EMA for central diabetes insipidus, nocturnal enuresis, nocturia and selected bleeding disorders.
What is the dose of Desmopressin (DDAVP)?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Desmopressin (DDAVP) is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.